Checkpoint Therapeutics, Inc. - Nilai perusahaan marang pendapatan CKPT

checkpointtx.com (CKPT) - logo korporat

High costs for cosibelimab tests and patents create barriers for competitors, while the EV/Sales ratio helps assess the business value excluding debt. The indicator shows the level of this metric. A stable R&D staff is maintained through stock options to retain talent. The Checkpoint Therapeutics (CKPT) brand is valued by oncologists for developing affordable and effective anti-cancer antibodies.

CKPT Rasio nilai perusahaan marang pendapatan Checkpoint Therapeutics Inc. (04.07.2022 - 20.11.2026)

Checkpoint Therapeutics Inc - rincian analitis lan metrik utama (CKPT)

Analisis wiwitan perusahaan:Checkpoint Therapeutics, Inc., CKPT
Barang utama Checkpoint Therapeutics, Inc

Patent protection for Cosibelimab within the skin cancer immunotherapy segment establishes a foundation for high future free cash flow and margins for Checkpoint Therapeutics (CKPT). By analyzing current EV/Sales dynamics, an investor assesses the total enterprise value including net debt relative to sales volume, which enables the determination of the asset's fair market value compared to industry peers.

Pesaing langsung

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan MURA|Kairos Pharma Ltd - Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio nilai perusahaan marang dodolan|Multiplikator EV/Sales CRIS (Curis, Inc.)|APLM: Rasio nilai perusahaan marang pendapatan|Tharimmune Corporation - Multiplikator EV/Sales|ADVB: Rasio nilai perusahaan marang pendapatan|GNPX: Multiplikator EV/Sales|CLDI (Calidi Biotherapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Sunshine Biopharma, Inc.|Multiplikator EV/Sales xeneticbio.com|Rasio nilai perusahaan marang pendapatan Salarius (SLRX)|Nilai perusahaan marang pendapatan Purple Biotech PPBT|Rasio nilai perusahaan marang pendapatan American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Multiplikator nilai perusahaan marang pendapatan|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan